Monoclonal Gammopathy–Associated Scleromyxedema Presenting as Leonine Facies [PDF]
, 2018 Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/146383/1/art40530.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/146383/2/art40530_am ...
Khanna, Dinesh +2 more
core +1 more source
Adverse reactions to the injection of face and neck aesthetic filling materials:a systematic review [PDF]
, 2023 Adverse reactions, caused during the inflammation and healing process, or even later, can be induced by the injection of dermal filler and can present a variety of clinical and histological characteristics.
Carvas, Janaína Badin +7 more
core +1 more source
A rare association of scleromyxedema with cutis verticis gyrata
Indian Dermatology Online Journal, 2016 Cutis verticis gyrata (CVG) is characterized by redundant skin on the scalp that exhibits deep furrows and convolutions. We report a 58-year-old male who presented with multiple raised asymptomatic skin-colored lesions over the chest and abdomen and ...
Savita Koregol +3 more
doaj +1 more source
Letter on 'European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis' [PDF]
, 2018 We read with interest the guidelines recently published on sclerosing diseases of the skin (Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis)[1, 2].
Blankestijn, Peter +4 more
core +2 more sources
JEADV Clinical Practice, EarlyView.ABSTRACT Background Scleromyxedema (SMX) is a cutaneous mucinosis characterised by an abnormal accumulation of mucin in the skin and limited treatment options. Assessment of therapy response during treatment is challenging. Objectives Patients with SMX receiving high‐dose intravenous IVIg therapy were included to assess validity of the double modified ...
Julia K. Winkler, Alexander H. Enk
wiley +1 more source
Case Reports in Dermatology, 2013 Scleromyxedema is a rare cutaneous mucinosis, usually presenting with generalized papular eruption and sclerodermoid induration, monoclonal gammopathy and systemic manifestations.
M. Dolenc-Voljč +3 more
doaj +1 more source
Scleromyxedema, a therapeutic dilemma
Indian Journal of Dermatology, 2015 Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described.
Julio Cesar Salas-Alanis +3 more
doaj +1 more source
Successful Treatment of Scleromyxedema with IVIG: A Case Report
Journal of Mazandaran University of Medical Sciences, 2018 Scleromyxedema (SM), a rare progressive cutaneous mucinosis with a systemic involvement, presents with progressive dermal mucin depositions, causing skin thickening.
Fatemeh Niksolat +5 more
doaj
Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database [PDF]
, 2017 Objective. To assess patients with SSc who present without circulating ANAs or RP. Methods. Five thousand three hundred and ninety patients who fulfilled the ACR criteria for SSc and were enrolled in the EULAR Scleroderma Trials and Research (EUSTAR ...
Carreira, Patricia E. +9 more
core
Systemic Sclerosis Mimics [PDF]
, 2019 Many clinical conditions are presenting with sclerosis of the skin and with tissue fibrosis. These conditions may be confused with systemic sclerosis (SSc, scleroderma).
Kodet, Ondřej, Oreská, Sabína
core +2 more sources